IPC Signs MoU to Strengthen Drug Quality & Safety

On 24th April 2026, Indian Pharmacopoeia Commission (IPC) signed MoUs with Pharmaceuticals and Medical Devices Bureau of India (PMBI) and National Institute of Pharmaceuticals Education and Research (NIPER), Hajipur, to promote Drug Quality, Research, and Patient Safety.

It focuses on quality assurance, rational use of medicines, and innovation in pharmaceutical standards.
The initiative strengthens India’s healthcare ecosystem and regulatory framework.
It also reinforces India’s position as a global leader in pharmaceutical quality and public health.
Indian Pharmacopoeia Commission sets standards for drugs in India and ensures their quality, safety, and efficacy.
Pharmaceuticals and Medical Devices Bureau of India implements the Jan Aushadhi scheme to provide affordable medicines.